Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Scandinavian Journal of Gastroenterology|March 3, 2022
Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre studyHeli Eronen, Sara Kolehmainen, Jukka Koffert, et al.
BMC Immunology|December 8, 2018
Small-intestinal TG2-specific plasma cells at different stages of coeliac diseaseMinna Hietikko, Outi Koskinen, Kalle Kurppa, et al.
Acta Dermato-Venereologica|November 29, 2017
Ex vivo Culture of Duodenal Biopsies from Patients with Dermatitis Herpetiformis Indicates that Transglutaminase 3 Antibody Production Occurs in the GutMinna Hietikko, Kaisa Hervonen, Tuire Ilus, et al.
Digestive Diseases and Sciences|September 22, 2018
Microbial Biomarkers in Patients with Nonresponsive Celiac DiseaseLiisa Viitasalo, Kalle Kurppa, Merja Ashorn, et al.
Journal of Clinical Gastroenterology|March 6, 2018
Dietary Factors and Mucosal Immune Response in Celiac Disease Patients Having Persistent Symptoms Despite a Gluten-free DietPilvi Laurikka, Katri Lindfors, Mikko Oittinen, et al.
The Journal of Investigative Dermatology|April 19, 2019
Gluten Challenge Induces Skin and Small Bowel Relapse in Long-Term Gluten-Free Diet-Treated Dermatitis HerpetiformisEriika Mansikka, Kaisa Hervonen, Katri Kaukinen, et al.
Acta Dermato-Venereologica|June 19, 2015
Dermatitis Herpetiformis Refractory to Gluten-free Dietary TreatmentKaisa Hervonen, Teea T Salmi, Tuire Ilus, et al.
Heliyon|July 8, 2024
Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatmentTero Ylisaukko-Oja, Clas-Göran Af Björkesten, Anja Eberl, et al.
Scandinavian Journal of Gastroenterology|April 6, 2021
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in FinlandTaina Sipponen, Clas-Göran Af Björkesten, Taru Hallinen, et al.
European Journal of Gastroenterology & Hepatology|September 2, 2020
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohortClas-Göran Af Björkesten, Tuire Ilus, Taru Hallinen, et al.
Pageof 2